Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021238
Filing Date
2023-05-11
Accepted
2023-05-11 16:11:41
Documents
79
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bdsx-20230331.htm   iXBRL 10-Q 2412911
2 EX-4.1 bdsx-ex4_1.htm EX-4.1 316388
3 EX-10.1 bdsx-ex10_1.htm EX-10.1 56762
4 EX-10.2 bdsx-ex10_2.htm EX-10.2 26223
5 EX-10.3 bdsx-ex10_3.htm EX-10.3 1404352
6 EX-31.1 bdsx-ex31_1.htm EX-31.1 18654
7 EX-31.2 bdsx-ex31_2.htm EX-31.2 18672
8 EX-32.1 bdsx-ex32_1.htm EX-32.1 10103
9 EX-32.2 bdsx-ex32_2.htm EX-32.2 10353
  Complete submission text file 0000950170-23-021238.txt   12412622

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsx-20230331_lab.xml EX-101.LAB 681039
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsx-20230331.xsd EX-101.SCH 81950
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdsx-20230331_def.xml EX-101.DEF 343477
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdsx-20230331_cal.xml EX-101.CAL 55935
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsx-20230331_pre.xml EX-101.PRE 509035
73 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20230331_htm.xml XML 1887584
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39659 | Film No.: 23911131
SIC: 8071 Services-Medical Laboratories